SIRT7通过调节BCAA和脂肪酸代谢来调节T细胞抗瘤免疫力
Zuojian Hu1,2, Yingji Chen3, Jielin Lei1
1Institute of Biomedicine Sciences & Shanghai Stomatological Hospital, Fudan University, Shanghai, China.
Cell death and differentiation
|March 27, 2025
概括
通过调节分支链氨基酸和脂肪酸代谢,SIRT7蛋白对T细胞功能和抗瘤免疫非常重要. 它的缺乏会损害T细胞的活动,并促进疲劳,突出显示SIRT7作为潜在的治疗点.
科学领域:
- 细胞的新陈代谢
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- SIRT7,一种Sirtuin家族成员,是一种NAD+依赖的脱乙酸酶和脱酸酶.
- 它在去糖化基质中的作用及其对细胞平衡的影响尚未完全理解.
- SIRT7主要表达在免疫组织中,特别是T细胞中.
研究的目的:
- 调查SIRT7在调节蛋白质化中的作用,特别是T细胞代谢和功能.
- 阐明SIRT7缺乏对T细胞中分支链氨基酸 (BCAA) 和脂肪酸 (FA) 代谢的影响.
- 确定向SIRT7在T细胞介导的抗瘤免疫中的治疗潜力.
主要方法:
- 在野生类型和Sirt7淘汰赛小鼠中的蛋白质组学,氨酸糖和乙烯酸分析.
- 线粒体局部化研究和SIRT7与BCAA代谢酶的蛋白质-蛋白质相互作用分析.
- 利用T细胞特异性的Sirt7淘汰赛小鼠模型来评估T细胞的增殖,激活和抗瘤功能.
主要成果:
- 在小鼠中,SIRT7 缺乏导致BCAA 代谢途径中蛋白质糖化增加.
- SIRT7与线粒体BCAA代谢酶相互作用,促进它们的脱化.
- 在T细胞中SIRT7淘汰会损害增殖,激活,抗瘤功能和细胞因子分泌,导致T细胞耗尽和代谢失调 (BCAA和FA积累).
结论:
- SIRT7是关键调节器,将BCAA和FA代谢与T细胞抗瘤免疫联系起来.
- 通过代谢变化,SIRT7缺乏会破坏T细胞的功能.
- 向SIRT7是一个潜在的治疗策略,可以增强T细胞介导的抗瘤反应.
相关概念视频
Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
T Cell Types and Functions
724
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
724
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Positive Regulator Molecules
105.6K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.6K


